NO20090322L - 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor - Google Patents
6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitorInfo
- Publication number
- NO20090322L NO20090322L NO20090322A NO20090322A NO20090322L NO 20090322 L NO20090322 L NO 20090322L NO 20090322 A NO20090322 A NO 20090322A NO 20090322 A NO20090322 A NO 20090322A NO 20090322 L NO20090322 L NO 20090322L
- Authority
- NO
- Norway
- Prior art keywords
- hiv
- inhibitor
- agent
- compound
- integrave
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006174331 | 2006-06-23 | ||
JP2006220082 | 2006-08-11 | ||
JP2006274143 | 2006-10-05 | ||
PCT/JP2007/062579 WO2007148780A1 (ja) | 2006-06-23 | 2007-06-22 | 6-(複素環置換ベンジル)-4-オキソキノリン化合物及びそのhivインテグラーゼ阻害剤としての利用 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090322L true NO20090322L (no) | 2009-03-20 |
Family
ID=38833517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090322A NO20090322L (no) | 2006-06-23 | 2009-01-21 | 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor |
Country Status (19)
Country | Link |
---|---|
US (1) | US7872004B2 (pt) |
EP (2) | EP2368880A1 (pt) |
JP (1) | JP4038231B1 (pt) |
KR (1) | KR101053811B1 (pt) |
AR (1) | AR061583A1 (pt) |
AU (1) | AU2007262010B2 (pt) |
BR (1) | BRPI0713336A2 (pt) |
CA (1) | CA2653830C (pt) |
CL (1) | CL2007001838A1 (pt) |
CO (1) | CO6150181A2 (pt) |
IL (1) | IL195862A0 (pt) |
MX (1) | MX2009000159A (pt) |
MY (1) | MY144773A (pt) |
NO (1) | NO20090322L (pt) |
NZ (1) | NZ573709A (pt) |
PE (1) | PE20080211A1 (pt) |
SA (1) | SA07280343B1 (pt) |
TW (1) | TW200811153A (pt) |
WO (1) | WO2007148780A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1564210B9 (en) * | 2002-11-20 | 2010-03-31 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
AR063710A1 (es) | 2006-09-12 | 2009-02-11 | Gilead Sciences Inc | Proceso para la preparacion de acido 6-(3-cloro-2-fluorbencil)-1-[(s)-1-hidroximetil-2-metilpropil]-7-metoxi-4-oxo-1, 4-dihidroquinolon-3-carboxilico como inhibidores de integrasa del hiv e intermediarios de sintesis del mismo y composiciones que lo comprenden. |
AR068403A1 (es) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
WO2011045330A1 (en) | 2009-10-13 | 2011-04-21 | Tibotec Pharmaceuticals | Macrocyclic integrase inhibitors |
JP5739517B2 (ja) | 2010-04-02 | 2015-06-24 | ヤンセン・アールアンドデイ・アイルランド | 大環状インテグラーゼ阻害剤 |
CA2856722C (en) | 2011-11-30 | 2022-11-22 | Emory University | Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
BR112015002275A2 (pt) | 2012-08-03 | 2017-07-04 | Gilead Sciences Inc | processos e intermediários para a preparação de inibidores da integrase |
KR20210142711A (ko) | 2019-03-22 | 2021-11-25 | 길리애드 사이언시즈, 인코포레이티드 | 가교된 트리시클릭 카르바모일피리돈 화합물 및 그의 제약 용도 |
JP7453399B2 (ja) | 2020-02-24 | 2024-03-19 | ギリアード サイエンシーズ, インコーポレイテッド | Hiv感染症を治療するための四環式化合物及びその使用 |
US11613546B2 (en) | 2021-01-19 | 2023-03-28 | Gilead Sciences, Inc. | Substituted pyridotriazine compounds and uses thereof |
TWI843506B (zh) | 2022-04-06 | 2024-05-21 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
CN115448866B (zh) * | 2022-10-13 | 2023-11-21 | 中北大学 | 一种1-甲基-2,3,4,5-四硝基吡咯的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0100051A3 (en) * | 1997-09-15 | 2002-08-28 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
AU2003236827A1 (en) | 2002-07-08 | 2004-01-23 | Coloplast A/S | Conduit device |
EP1564210B9 (en) * | 2002-11-20 | 2010-03-31 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
ATE482208T1 (de) | 2004-03-10 | 2010-10-15 | Us Of America Represented By T | Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids- related complex (arc) |
US7531554B2 (en) * | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
WO2006033422A1 (ja) | 2004-09-21 | 2006-03-30 | Japan Tobacco Inc. | キノリジノン化合物、およびそのhivインテグラーゼ阻害剤としての利用 |
US7745459B2 (en) * | 2004-09-21 | 2010-06-29 | Japan Tobacco Inc. | Quinolizinone compound and use thereof as HIV integrase inhibitor |
JP2006174331A (ja) | 2004-12-20 | 2006-06-29 | Fuji Xerox Co Ltd | 画像圧縮装置、画像圧縮方法及びそのプログラム |
JP2006220082A (ja) | 2005-02-10 | 2006-08-24 | Denso Corp | 燃料噴射装置 |
JP4572720B2 (ja) | 2005-03-30 | 2010-11-04 | Dic株式会社 | 水分散型アクリル系樹脂の製造方法、並びにそれにより製造される水分散型アクリル粘着剤組成物及び粘着シート |
DE102006005861A1 (de) | 2006-02-09 | 2007-08-23 | Aicuris Gmbh & Co. Kg | Substituierte Chinolone III |
-
2007
- 2007-06-21 TW TW096122234A patent/TW200811153A/zh unknown
- 2007-06-22 EP EP11168760A patent/EP2368880A1/en not_active Withdrawn
- 2007-06-22 MX MX2009000159A patent/MX2009000159A/es active IP Right Grant
- 2007-06-22 PE PE2007000805A patent/PE20080211A1/es not_active Application Discontinuation
- 2007-06-22 KR KR1020097001497A patent/KR101053811B1/ko not_active IP Right Cessation
- 2007-06-22 JP JP2007164676A patent/JP4038231B1/ja not_active Expired - Fee Related
- 2007-06-22 AU AU2007262010A patent/AU2007262010B2/en not_active Ceased
- 2007-06-22 CL CL200701838A patent/CL2007001838A1/es unknown
- 2007-06-22 WO PCT/JP2007/062579 patent/WO2007148780A1/ja active Application Filing
- 2007-06-22 BR BRPI0713336-7A patent/BRPI0713336A2/pt not_active IP Right Cessation
- 2007-06-22 AR ARP070102755A patent/AR061583A1/es not_active Application Discontinuation
- 2007-06-22 CA CA2653830A patent/CA2653830C/en not_active Expired - Fee Related
- 2007-06-22 EP EP07845259A patent/EP2033954A4/en not_active Withdrawn
- 2007-06-22 US US11/767,021 patent/US7872004B2/en not_active Expired - Fee Related
- 2007-06-22 NZ NZ573709A patent/NZ573709A/en not_active IP Right Cessation
- 2007-06-23 SA SA7280343A patent/SA07280343B1/ar unknown
-
2008
- 2008-12-10 MY MYPI20085006A patent/MY144773A/en unknown
- 2008-12-11 IL IL195862A patent/IL195862A0/en unknown
-
2009
- 2009-01-16 CO CO09003378A patent/CO6150181A2/es unknown
- 2009-01-21 NO NO20090322A patent/NO20090322L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2007262010B2 (en) | 2011-05-12 |
AU2007262010A1 (en) | 2007-12-27 |
KR101053811B1 (ko) | 2011-08-03 |
CL2007001838A1 (es) | 2008-02-08 |
CO6150181A2 (es) | 2010-04-20 |
CA2653830C (en) | 2011-11-22 |
SA07280343B1 (ar) | 2011-01-15 |
MX2009000159A (es) | 2009-01-23 |
BRPI0713336A2 (pt) | 2012-11-06 |
WO2007148780A1 (ja) | 2007-12-27 |
US7872004B2 (en) | 2011-01-18 |
JP4038231B1 (ja) | 2008-01-23 |
TW200811153A (en) | 2008-03-01 |
CA2653830A1 (en) | 2007-12-27 |
JP2008110960A (ja) | 2008-05-15 |
IL195862A0 (en) | 2009-09-01 |
EP2368880A1 (en) | 2011-09-28 |
EP2033954A4 (en) | 2009-08-12 |
US20080207618A1 (en) | 2008-08-28 |
PE20080211A1 (es) | 2008-04-23 |
KR20090023731A (ko) | 2009-03-05 |
NZ573709A (en) | 2011-04-29 |
EP2033954A1 (en) | 2009-03-11 |
AR061583A1 (es) | 2008-09-03 |
MY144773A (en) | 2011-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090322L (no) | 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor | |
TW200510425A (en) | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor | |
MY136173A (en) | 4-oxoquinoline compound and use thereof as hiv integrase inhibitor | |
MX2022000563A (es) | Derivado de adenosina y composición farmacéutica que lo comprende. | |
MX2019007262A (es) | Compuestos antivirales de bencilamina fosfodiamida. | |
NO20045152L (no) | Ikke-nukleosid-reverstranskriptaseinhibitorer | |
NO20063958L (no) | HIV integrase inhibitorer | |
NO20080913L (no) | HIV-revers-transriptaseinhibitorer | |
EA200970572A1 (ru) | Ненуклеозидные ингибиторы обратной транскриптазы | |
CA2998646C (en) | 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof | |
MA34002B1 (fr) | Thérapie antivirale | |
UA114006C2 (xx) | Похідні 5-фенокси-3h-піримідин-4-ону і їхнє застосування як інгібіторів зворотної транскриптази віл | |
EA200601654A1 (ru) | Ингибиторы интегразы вич | |
NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
WO2008010953A3 (en) | Pyridinone diketo acids: inhibitors of hiv replication in combination therapy | |
CL2008003786A1 (es) | Compuestos derivados de 1h-pirazolo[3,4-c]piridazinilo, 1h pirazolo[3,4-b]piridinilo, ah-pirazolo[3,4-c]piridinilo e indazolilo, inhibidores no nucleosidicos de la transcriptasa reversa del vih-1(nnrti); composicion fa<rma<ceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por viv, sida o arc. | |
TW200738700A (en) | HIV integrase inhibitors | |
GEP20156368B (en) | Non-nucleoside reverse transcriptase inhibitors | |
EA201170537A1 (ru) | Ингибиторы вич-интегразы | |
SG155939A1 (en) | Phosphoindoles as hiv inhibitors | |
WO2006083553A3 (en) | Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase | |
WO2007002481A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2007019101A3 (en) | Hiv integrase inhibitors | |
EA202191711A1 (ru) | Производные пиримидона в качестве селективных цитотоксических агентов против вич-инфицированных клеток | |
WO2007019100A3 (en) | Hiv integrase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |